Cite
HARVARD Citation
Gershenson, D. et al. (n.d.). LBA61A randomized phase II/III study to assess the efficacy of trametinib in patients with recurrent or progressive low-grade serous ovarian or peritoneal cancer. Annals of oncology. p. . [Online].